有形股本回报率 ％是由公司的 扣除优先股股利的归母净利润 除以该公司一段时期内的平均有形所有者权益而得。

** 在计算季度（年化）数据时，使用的 扣除优先股股利的归母净利润 数据是 季度 （2024年3月） 扣除优先股股利的归母净利润 数据的4倍。

有形股本回报率 ％反映股东有形所有者权益的收益水平，用以衡量公司运用有形所有者权益产生利润的效率。在15％到20％之间的有形股本回报率 ％被认为是可取的。

计算有形股本回报率 ％的时候使用的是 扣除优先股股利的归母净利润 。

由于公司可以通过增加财务杠杆来提高有形股本回报率 ％，所以在投资有形股本回报率 ％高的公司时，一定要注意权益乘数。 与 有形资产收益率 ％ 一样，有形股本回报率 ％也仅用12个月的数据来计算。公司收入或业务周期的波动会严重影响该比率，因此从长期角度看待该比例很重要。

轻资产业务仅用很少的资产就能产生很高的收益，他们的有形股本回报率 ％可能非常高。

一级行业：非周期性消费
二级行业：农副加工食品
公司网站：https://www.kenvue.com
公司地址：199 Grandview Road, Skillman, NJ, USA, 08558
公司简介：Kenvue is the world's largest pure-play consumer health company by sales, generating $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of silos within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio includes a wide array of some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Despite playing in a fragmented industry with intense competition and ever-changing consumer preferences, many of Kenvue's brands are the global leader in their respective segment thanks to their strong brand power.